Exclusive: China's Sciwind is in talks to license weight-loss drug in US, CEO says – Reuters

Written by

admin

in

  1. Exclusive: China’s Sciwind is in talks to license weight-loss drug in US, CEO says  Reuters
  2. Hengrui Pharma targets obesity drug launch after test success  thebambooworks.com
  3. Navigating the GLP-1 Opportunity In China: Strategic Imperatives For Western Pharma  insights.citeline.com
  4. China’s Sciwind is in talks to license weight-loss drug in US, CEO says  PharmaLive

Continue Reading

More posts